Life Science Angel Investor's Panel: Trends for 2009
Life Science Angel Investor's Panel:
Life science angel investors are generally seasoned executives with deep strategic and operational experience in running successful life science businesses, from concept to clinical trials to regulatory approvals, manufacturing and distribution. They generally also have extensive experience within corporations in various roles, and continue to develop these partnerships as they support their portfolio companies.
The life science angel investors we’ve recruited for this month’s panel have been seen a wide range of life science business models, and have their own thoughts and recommendations on how to be successful in these challenging times. Topics will include how early stage companies can:
– position themselves for successful partnerships and fundings,
– strategically plan your business based on evolving market needs,
– tightly manage cash flow, and
– build strategic alliances with larger organizations, angels, research organizations, and other key stakeholders
Facilitator: Rahul Pathak, Partner, Jones Day
• Angel Panelists:
o Stuart Eckmann, Keiretsu Forum and Life Science Angels (Bio and Device Committees)
o Elaine Heron, Life Science Angels and LabCyte
o Anne DeGheest, MedStars
o Don Ross, Life Science Angels and Sand Hill Angels
• Featured Recently-Funded Entrepreneurs:
o Mitchell Mutz, CSO, Amplyx Pharmaceuticals
o Michelle Stecklein Call, CEO, Lypro BioScience
Monday, 01/26/09
Contact:
Website: Click to VisitCost:
$20 members, $25 partners, $30 generalSave this Event:
iCalendarGoogle Calendar
Yahoo! Calendar
Windows Live Calendar
